Evaluation of Lomecel-B™ Injection in Patients With Hypoplastic Left Heart Syndrome (HLHS): A Phase IIb Clinical Trial.
Study sponsor: Longeveron Inc. · LGVN
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2026-06-30Estimated
Enrollment · participants40Actual
Source updated2025-06-25Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.